Carregant...
Effect of the cannabinoid receptor–1 antagonist rimonabant on inflammation in mice with diet-induced obesity
We studied whether CB1 blockade with rimonabant has an anti-inflammatory effect in obese mice, and whether this effect depends on weight loss and/or diet consumption. High-fat diet (HFD)–induced obese mice were treated orally with rimonabant (HFD-R) or vehicle (HFD-V) for 4 weeks. Paired-feeding was...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3272877/ https://ncbi.nlm.nih.gov/pubmed/20885384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/oby.2010.213 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|